Literature DB >> 26044167

Prospective Randomized Long-Term Study on the Efficacy and Safety of UV-Free Blue Light for Treating Mild Psoriasis Vulgaris.

Stephanie Pfaff1, Jörg Liebmann, Matthias Born, Hans F Merk, Verena von Felbert.   

Abstract

BACKGROUND: Blue light irradiation reduces the proliferation of keratinocytes and modulates T-cell immune response in vitro and has been shown to reduce the severity of psoriasis vulgaris (Pv) in two clinical trials.
OBJECTIVE: Evaluation of safety and efficacy of long-term UV-free blue light treatment at home for mild Pv.
METHODS: Forty-seven patients with mild Pv were randomized for receiving high-intensity blue light treatment (HI: 453 nm LED, 200 mW/cm(2), n = 24) and low-intensity treatment (LI: 453 nm LED, 100 mW/cm(2), n = 23) of one Pv plaque for 12 weeks. A contralateral control plaque remained untreated.
RESULTS: Patient compliance and satisfaction were high. The primary endpoint, change from baseline (CfB) of the Local Psoriasis Severity Index, revealed a significant improvement of the target compared to the control plaques (ΔCfB for the HI group: -0.92 ± 1.10, p = 0.0005; for the LI group: -0.74 ± 1.18, p = 0.0064).
CONCLUSION: UV-free blue light home treatment is safe and improves Pv plaques.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26044167     DOI: 10.1159/000430495

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  14 in total

1.  Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light.

Authors:  Hannah Serrage; Vladimir Heiskanen; William M Palin; Paul R Cooper; Michael R Milward; Mohammed Hadis; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2019-06-11       Impact factor: 3.982

2.  Shedding light on the variability of optical skin properties: finding a path towards more accurate prediction of light propagation in human cutaneous compartments.

Authors:  C Mignon; D J Tobin; M Zeitouny; N E Uzunbajakava
Journal:  Biomed Opt Express       Date:  2018-01-29       Impact factor: 3.732

Review 3.  Visible light. Part I: Properties and cutaneous effects of visible light.

Authors:  Evan Austin; Amaris N Geisler; Julie Nguyen; Indermeet Kohli; Iltefat Hamzavi; Henry W Lim; Jared Jagdeo
Journal:  J Am Acad Dermatol       Date:  2021-02-25       Impact factor: 11.527

4.  A Dynamic Model for Prediction of Psoriasis Management by Blue Light Irradiation.

Authors:  Zandra C Félix Garza; Joerg Liebmann; Matthias Born; Peter A J Hilbers; Natal A W van Riel
Journal:  Front Physiol       Date:  2017-01-26       Impact factor: 4.566

Review 5.  A clinical review of phototherapy for psoriasis.

Authors:  Ping Zhang; Mei X Wu
Journal:  Lasers Med Sci       Date:  2017-10-24       Impact factor: 3.161

6.  Photobiomodulation of human dermal fibroblasts in vitro: decisive role of cell culture conditions and treatment protocols on experimental outcome.

Authors:  C Mignon; N E Uzunbajakava; B Raafs; N V Botchkareva; D J Tobin
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

Review 7.  Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.

Authors:  Ana M Martins; Andreia Ascenso; Helena Margarida Ribeiro; Joana Marto
Journal:  Mol Neurobiol       Date:  2020-02-15       Impact factor: 5.590

8.  Gene expression profiling reveals aryl hydrocarbon receptor as a possible target for photobiomodulation when using blue light.

Authors:  Anja Becker; Anna Klapczynski; Natalia Kuch; Fabiola Arpino; Katja Simon-Keller; Carolina De La Torre; Carsten Sticht; Frank A van Abeelen; Gerrit Oversluizen; Norbert Gretz
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

Review 9.  Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects.

Authors:  Sylvie M Franken; Carlijn L Vierstra; Thomas Rustemeyer
Journal:  Psoriasis (Auckl)       Date:  2016-05-18

10.  Inhibition of Proliferation in U937 Cells Treated by Blue Light Irradiation and Combined Blue Light Irradiation/Drug.

Authors:  Jianjian Zhuang; Junsong Liu; Xuan Gao; Hongdong Li
Journal:  Int J Mol Sci       Date:  2018-05-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.